Upcoming Events at the San Diego Chapter

Chapter Homepage

"The Virtual Company"

The meeting will be held on

Thursday, November 15, 2007
6:00-8:00 p.m.

NOTICE:

LES San Diego hopes that all of its members are in good health.  Our thoughts are with those residents of San Diego County, especially any of our members, who lost property during the recent fires.

This meeting was originally scheduled for the month of October but was cancelled due to the fires.  If you had already signed up for the October meeting, your are registered for this meeting and need not register again.  If you had registered for the October meeting, but cannot attend the November meeting, please contact Sam Tahmassebi (contact information below) for a refund.  We, of course, look forward to seeing all of you on November 15^th.

THE NOVEMBER MEETING WILL BE HELD AT THE HILTON LA JOLLA TORREY PINES

PARTIAL LIST OF PANEL MEMBERS:
Keith Posehn, entrepreneur and consultant
Nicholas A. Boyle, Ph.D., co-founder, CEO, and President of AlisTech
Mark Benedyk, Vice President, Business Development, Ascenta
Robert P. Cogan, Partner, The Nath Law Group (Moderator)

PROGRAM DESCRIPTION:
The virtual company is not virtual; it is real.  At the November LES San Diego Chapter meeting, we will have entrepreneurs discuss their experience in operations, problem solving, and strategy in businesses without a traditional headquarters.  Find out how these companies interact with both the big traditional companies and with individual contributors.

Sponsored by:

To learn more, please join us on Thursday, November 15 at the Licensing Executives Society (LES) Meeting at the Hilton La Jolla Torrey Pines.

DATE:
Thursday, November 15, 2007

TIME:
6:00 p.m. – 6:50 Registration, Networking, Cocktails and Appetizers
6:50 p.m. – 7:00 p.m. Chapter Business
7:00 p.m. – 8:00 p.m. Speaker Presentation

LOCATION:
Hilton La Jolla Torrey Pines
10950 North Torrey Pines Road
La Jolla, CA  92037

COST:
Pre-Register by 12 noon on Tuesday, November 13, 2007

$35 Members by Tuesday, November 13, $45 at the door (cash or check only)
$40 Non-Members by Tuesday, November 13, $50 at the door (cash or check only)

$20 Member Student Rate by Tuesday, November 13, $20 at the door (cash or check only)
$25 Non-Member Student Rate by Tuesday, November 13, $25 at the door (cash or check only)

REGISTRATION:

Pre-registration not only guarantees you a seat, but it also saves you $10.

1) Register Online and pay with a credit card

LES Members and online account holders:
To register online for this event you will need your log in and password. Please click here to register.

LES Student Members and online account holders:
To register online for this event you will need your log in and password. Please click here to register.

Non LES Members:
You will need to create an account prior to registering for this event.
Please click here to create an account.

Once your account has been created proceed to registration as an online account holder.

Seating is limited and will be on a first come, first served basis. Please note that we will still need to receive your reservation by Tuesday, November 13, to guarantee your registration.

2) Register by check:
Please mail your check to:

Sam K. Tahmassebi
Biotechnology Law Group
10755 Scripps Poway Parkway, Suite 373
San Diego, CA 92131
619-203-2579
e-mail: sam@biotechnologylawgroup.com

For additional information, please contact:

Sam K. Tahmassebi, Chair
Tel: 619-203-2579
Fax:  858-350-9691
e-mail: sam@biotechnologylawgroup.com

NOTE:   This presentation will qualify for MCLE credit

PANELISTS’ BIOGRAPHY

Keith Posehn is an entrepreneur and consultant with several years experience developing video games, monetizing business models, and creating new startup companies. Starting his experience in the video game industry with the Strike™ series by Electronic Arts, he moved into consulting at the turn of the century. He serves as Chief Scientific Officer of Bang Out Games whose business model includes selling “casual” games designed by independent writers through affiliate networks.

Nicholas A. Boyle, Ph.D. is a co-founder and the CEO and President AlisTech. He initiated a study of appropriate drug technologies that culminated in the licensing of intellectual property for the supportive care of animals and humans undergoing cancer therapy. Dr. Boyle’s experience is in pharma as a medicinal chemist with SmithKline Beecham, in biotechnology at Biota Inc. and in academia in fields including oncology, HIV, stroke, and neurodegeneration. He is an author on 16 publications, 4 patents (issued or pending) and has delivered presentations at major international conferences. Dr. Boyle completed post-doctoral research at The Scripps Research Institute and earned his Ph.D. in organic chemistry at Sheffield University.

Mark Benedyk, Ph.D.  is the Vice President, Business Development, Ascenta Therapeutics, Inc.  Prior to joining Ascenta in May 2005, Dr. Benedyk was Vice President of Business Development and Director of Optimer Biotechnology, an international biotechnology firm with operations in the U.S., Singapore and Taiwan. Previously, Dr. Benedyk has held business development positions at rila bioconsulting, Farmal Biomedicines, Aurora Biosciences (now Vertex Pharmaceuticals), Élan Pharmaceuticals, and Argonex Corporation. During his tenure in the pharmaceutical and biotechnology industries, Dr. Benedyk personally led transactions worth over $250 million and participated in over $500 million worth of product licensing and corporate acquisition transactions overall. Dr. Benedyk received his Ph.D. in Genetics and Developmental Biology from The Rockefeller University, where he was a Lucille P. Markey Graduate Fellow. His B.S. in Microbiology and Botany was received from the University of Michigan.

Robert P. Cogan, the moderator for the discussion, is a Partner in the San Diego office of The Nath Law Group, an intellectual property law firm based in the Washington, DC area. Mr. Cogan is a patent attorney with an electrical engineering background. He provides legal advice on intellectual property matters to a wide spectrum of clients including companies in the high technology, medical device, light and heavy industrial, commercial and financial sectors as well as universities and individual entrepreneurs. Before moving into private practice, Mr. Cogan practiced law for more than twenty years as an in-house patent attorney for several large corporations. As chief patent counsel for EG&G, a Fortune 200 company, he drafted and supervised the drafting and prosecution of patent applications across a wide variety of technology disciplines, advised operational personnel on intellectual property aspects in many different business situations and played a managerial role within the Corporation. This broad range of experience provides Mr. Cogan with strong expertise in advising and counseling companies operating in today's fast-paced environment.